Marc de Garidel

Insider Reports History

Entity
Individual
Location
C/O Cincor Pharma, Inc., 200 Clarendon Street, 6 Th Floor, Boston, MA
Signature
/s/ Amanda Gonzalez Burton, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marc de Garidel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CinCor Pharma, Inc. Chief Executive Officer, Director Common Stock 0 $28.75 Feb 24, 2023 Direct
CinCor Pharma, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 0 Feb 24, 2023 Direct

Insider Reports Filed by Marc de Garidel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CINC CinCor Pharma, Inc. Feb 24, 2023 4 $0 4 Feb 24, 2023 Chief Executive Officer, Director
CINC CinCor Pharma, Inc. Jan 26, 2023 1 $0 4 Jan 30, 2023 Chief Executive Officer, Director
CINC CinCor Pharma, Inc. Jan 11, 2022 1 $200K 4 Jan 13, 2022 Chief Executive Officer, Director
CINC CinCor Pharma, Inc. Jan 6, 2022 0 $0 3 Jan 6, 2022 Chief Executive Officer, Director